Emergency Medicine Reports (Vol. 37 No.3) February 1,…

February 1, 2016

View Issues

Diabetic Ketoacidosis

MONOGRAPH: It's characterized by markedly increased circulating ketone bodies leading to ketoacidosis.

Read more about Diabetic Ketoacidosis - No Issue

Issue Date: February 1, 2016

Financial Disclosure: To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Dr. Farel (CME question reviewer) owns stock in Johnson & Johnson. Dr. Stapczynski (editor) owns stock in Pfizer, Johnson & Johnson, Walgreens Boots Alliance Inc., GlaxoSmithKline, Bristol Myers Squibb, and AxoGen. Dr. Wise (editor) reports he is on the speakers bureau for the Medicines Company. Dr. Kabadi (author) reports he is a consultant and on the speakers bureau for Sanofi. Dr. Shubrook (peer reviewer) reports he receives grant/research support from Sanofi and is a consultant for Eil Lilly, Novo Nordisk, and Astra Zeneca. Dr. Schneider (editor), Dr. Acharya (author), Ms. Coplin (executive editor), Ms. Mark (executive editor), Mr. Landenberger (editorial and continuing education director), and Mr. Springston (associate managing editor) report no financial relationships relevant to this field of study.

Emergency Medicine Reports – February 1, 2016

February 1, 2016

Diabetic Ketoacidosis